A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.

Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

Comedian, talk show host and advocate Jon Stewart spoke last week to a crowd of Vanderbilt undergraduates, medical students and faculty about his approach to advocacy and how those in the medical community can find their own place alongside those supporting a cause.

Cecelia Theobald, MD, MPH, has been appointed as Vanderbilt University Medical Center’s Chief of Staff for Corporate Clinical Affairs and Senior Vice President for Clinical Affairs.

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.